Founded in 2022 and headquartered in Boston, Stellaromics is revolutionizing biomedical research with its proprietary technology, unraveling complex 3D transcription and translation patterns within native biological tissue. At the forefront of their innovation is STARmap (Spatially-resolved Transcript Amplicon Readout mapping), their flagship product. STARmap empowers researchers to uncover gene expression patterns within intact tissue, facilitating the pinpointing of treatment targets and bolstering biomedical investigations.

Stellaromics is currently in the advanced stages of developing its Plexa™ suite of products, meticulously crafted to empower researchers and clinicians in the creation of intricate cellular maps, thereby amplifying our comprehension of various diseases.

For comprehensive details, we invite you to explore our website at stellaromics.com. Join us in shaping the future of biomedical research.


Biotechnology

Life Sciences

Mapping

Medical Devices

Research

Stellaromics Inc.

Stellaromics Inc.'s headquarters in Boston, United States

This department focuses on leveraging data science and computational biology to drive research and innovation.

Data Science Division

This department focuses on conducting scientific investigations and analyses to advance knowledge and innovation.

Research Division

This department focuses on the development, implementation, and maintenance of software applications and systems.

Software Engineering

This department focuses on the integration and support of systems and products to ensure seamless functionality and performance.

System Integration

This department focuses on the application of computational techniques to analyze biological data and advance research in the life sciences.

Computational Biology

This department focuses on providing engineering solutions and support across various technical domains.

People (3)

Jobs (0)

Other teams

Research Division

Software Engineering

System Integration

Computational Biology

Engineering Services